
	Where results make sense

Topic: Rofecoxib

Related Topics

Celecoxib

Valdecoxib

Cyclooxygenase

Indomethacin

Naproxen

Clinical trial

Piroxicam

Ibuprofen

Diclofenac

Paracetamol

Ketoprofen

Mefenamic acid

Acetaminophen

Nimesulide

Prostaglandin

In the News (Sat 31 Jan 15)

EXECUTIVE POWER

Iran

ANALYSIS

Pakistan

Family compact

	Rheumatoid Arthritis: Encyclopedia of Medicine
		Unlike the NSAIDs, the COX-2 inhibitors do not carry a high risk of gastrointestinal ulcers and bleeding, because they do not inhibit COX-1, which is the enzyme that protects the stomach lining.
		Celecoxib has been approved by the FDA for the treatment of RA and osteoarthritis, and is taken once or twice daily by mouth.
		Rofecoxib is approved for RA and osteoarthritis, and for acute pain caused by primary dysmenorrhea and surgery.
	health.enotes.com /medicine-encyclopedia/rheumatoid-arthritis (2348 words)

	MedlinePlus Drug Information: Rofecoxib
		Merck & Co., Inc. announced a voluntary withdrawal of rofecoxib (Vioxx) from the U.S. and worldwide market due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients on rofecoxib.
		Rofecoxib is used to relieve the pain, tenderness, inflammation (swelling), and stiffness caused by arthritis and to treat painful menstrual periods and pain from other causes.
		Rofecoxib is in a class of nonsteroidal anti-inflammatory medications (NSAIDs) called COX-2 inhibitors.
	www.nlm.nih.gov /medlineplus/druginfo/medmaster/a699046.html (752 words)

	Vioxx Drug Description - Rofecoxib - HealthScout
		On Sept. 30, 2004 Merck & Co., Inc. announced a voluntary worldwide withdrawal of VIOXX® (rofecoxib).
		Please be aware that the information below is provided only for reference.
		To find more information on specific conditions, please visit our partner sites:
	www.healthscout.com /rxdetail/1/73/1/main.html (61 words)

Try your search on: Qwika (all wikis)